Drugs Made in America Acquisition Corp. (DMAAU) Prices $200M IPO
by Nicholas Alan Clayton on 2025-01-27 at 5:40pm

Drugs Made in America Acquisition Corp. (NASDAQ:DMAAU) announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “DMAAU”, Tuesday, January 28, 2025.

The new SPAC intends to combined with a target company in the pharmaceutical industry that has products derived from plant-based raw materials.

Drugs Made in America’s sponsor team is led by Chief Executive Officer and Executive Chair Lynn Stockwell, and Chief Financial Officer Glenn Worman. Catherine Do, Sridhar Prasad and Myron W. Shulgan will serve on its Board of Directors.

Total SPAC deal count for 2025 year-to-date is now 6. This offering is expected to close on Wednesday, January 29, 2025.


Clear Street is acting as the sole book-running manager in the offering. Loeb & Loeb LLP is serving as Issuer’s Counsel with Winston & Strawn LLP serving as Underwriter’s Counsel. MaloneBailey LLP serves as auditor. Wilmington Trust, National Association is acting as trustee.

Recent Posts
by Kristi Marvin on 2025-02-14 at 8:16am

At the SPAC of Dawn  Lost in the daily assault of A.I. company news are all of the “other” companies that were created in the past decade or so. The normies. These venture-backed companies that achieved unicorn status during the boom years of 2020 and 2021 have been sidelined and much has been discussed about...

by Kristi Marvin on 2025-02-14 at 6:50am

Quantum computing has been one of the hottest investment topics in the past two months and three of the leading listed companies in the space are de-SPACs. But, how close is quantum computing to generating real value and what capabilities are still years away? This week, we speak with Alan Baratz, CEO of D–Wave (NYSE:QBTS), which...

by Nicholas Alan Clayton on 2025-02-13 at 8:19am

At the SPAC of Dawn  The sudden burst of SPAC activity this week slowed down after the closing bell yesterday as the market faces a period sandwiched between CPI and PPI readouts. Yesterday’s CPI news and Fed Chair Jerome Powell’s comments before Congress did not provide an instant relief in terms of clarity on a...

by Kristi Marvin on 2025-02-12 at 5:34pm

Maywood Acquisition Corp. (NASDAQ:MAYAU) announced the pricing of its $75 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “MAYAU”, Thursday, February 13, 2025. Maywood will have a broad search focus and will pursue an initial business combination in any industry or geographic location. The team is led...

by Nicholas Alan Clayton on 2025-02-12 at 5:20pm

Artius II Acquisition Inc. (NASDAQ:AACBU) announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “AACBU”, Thursday, February 13, 2025. Artius II intends to search for a target company with a technology-enabled business with opportunities that have multiple vectors to create value post-combination....

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved